DSM-Firmenich reported weakness in beauty ingredient sales in its half-year financial results due to weaker demand for sun filters.
The Dutch-Swiss company’s Perfumery & Beauty division recorded a 1% dip in sales in the first six months of 2025 compared to the same period last year - from €2.007 billion ($2.3 billion) to €1.989 billion.
EBITDA (earnings before interest, taxes, depreciation and amortization of property, plant and equipment and intangible assets) fell 4% over the same period to €438 million.
“Beauty & Care experienced challenges in sun filters due to weak end-user demand and customer destocking,” the company said in a statement.
Overall, DSM-Firmenich notched a 3% increase in sales in the first half of 2025 to €6.5 billion and EBITDA growth of 29% to €1.26 billion.
“We are pleased to report a good performance in the first six months, with good organic sales and earnings growth and the effective execution of our strategic plan,” said CEO Dimitri de Vreeze.
“With our broad exposure to key market trends in nutrition, health and beauty, we deliver innovative solutions that provide critical performance to essential everyday consumer products,” he added.
“Our focus on innovation-led growth, and the €200 million contribution from our self-help programs support our full-year 2025 outlook of around €2.4 billion in adjusted EBITDA.”
